EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Xlife Sciences AG's enterprise value is CHF257.63 Mil.
Xlife Sciences AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF20.95 Mil. Therefore, Xlife Sciences AG's EV-to-EBITDA for today is 12.30.
The historical rank and industry rank for Xlife Sciences AG's EV-to-EBITDA or its related term are showing as below:
XSWX:XLS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.91 Med: 19.64 Max: 25.29
Current: 12.3
During the past 6 years, the highest EV-to-EBITDA of Xlife Sciences AG was 25.29. The lowest was 5.91. And the median was 19.64.
XSWX:XLS's EV-to-EBITDA is ranked worse than 56.99% of 465
companies
in the Biotechnology industry
Industry Median: 9.34
vs XSWX:XLS: 12.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Xlife Sciences AG EV-to-EBITDA Historical Data
The historical data trend for Xlife Sciences AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xlife Sciences AG's EV-to-EBITDA
For the Biotechnology subindustry, Xlife Sciences AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xlife Sciences AG's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Xlife Sciences AG's EV-to-EBITDA falls into.
Xlife Sciences AG's current Enterprise Value is CHF257.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF20.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xlife Sciences AG (XSWX:XLS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Xlife Sciences AG's PE Ratio for today is calculated as:
Xlife Sciences AG's share price for today is CHF35.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.080.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Xlife Sciences AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:XLS has been successfully added to your 